Home
About the Company
Technology
News
Jobs
Contact
 


AMES Technology Inc., has developed and is bringing to market a new non-invasive, patented technology which has been shown in clinical trials to reduce impairment and improve function in highly disabled stroke patients and incomplete spinal cord injured patients.

A 510(k) Class II Clearance from the FDA, to market and sell the AMES R300 Rehab Therapy Device, was received on May 24, 2013.








 Top